| Product NDC: | 0004-0261 |
| Proprietary Name: | CellCept |
| Non Proprietary Name: | Mycophenolate Mofetil |
| Active Ingredient(s): | 200 mg/mL & nbsp; Mycophenolate Mofetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0261 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050759 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980812 |
| Package NDC: | 0004-0261-29 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC |
| NDC Code | 0004-0261-29 |
| Proprietary Name | CellCept |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) > 225 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 0004-0261 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mycophenolate Mofetil |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19980812 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | MYCOPHENOLATE MOFETIL |
| Strength Number | 200 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |